AGFAGDDAPR

Revisión del cliente

Based on 1 Customer Validation

AGFAGDDAPR is a bioactive peptide that is a competitive and orally effective inhibitor of dipeptidyl peptidase-IV (DPP-IV). AGFAGDDAPR can enhance the level of GLP-1 in the body by inhibiting DPP-IV, thereby stimulating insulin secretion, improving β-cell function, and inhibiting abnormal proliferation of α-cells, exerting anti-diabetic effects. AGFAGDDAPR can be used for research on type 2 diabetes.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • No. CAS: 330204-04-1
  • Fòrmula: C41H61N13O15
  • Peso molecular:976.00
  • Almacenamiento:

    Sealed storage, away from moisture.

    Powder   -80°C, 2 years , -20°C, 1 year

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Ver todos los productos específicos de isoformas Dipeptidyl Peptidase

More
100 mg

Obtener un presupuesto En stock

Please select quantity
Amount: USD 0.00